Fabio Maino

Siena, 53100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Familial Status Modulates the Stability of Excellent Response in Non-Medullary Thyroid Carcinoma: Implications for Tailored Surveillance.

Familial Status Modulates the Stability of Excellent Response in Non-Medullary Thyroid Carcinoma: Implications for Tailored Surveillance.

Journal: Cancers

Published: March 25, 2026

Letter to the Editor From Maino et al: "Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules: A Systematic Review of Literature and Meta-analysis".

Letter to the Editor From Maino et al: "Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules: A Systematic Review of Literature and Meta-analysis".

Journal: The Journal of clinical endocrinology and metabolism

Published: May 19, 2025

Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer.

Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: May 11, 2024

Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world Analysis.

Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world Analysis.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 26, 2024

Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients.

Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients.

Journal: Journal of endocrinological investigation

Published: August 10, 2023

Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer.

Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer.

Journal: Cancers

Published: July 20, 2023

Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients.

Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients.

Journal: Journal of endocrinological investigation

Published: March 18, 2023

Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.

Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 21, 2023

Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer.

Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer.

Journal: International journal of molecular sciences

Published: February 03, 2023

Radioiodine therapy in the different stages of differentiated thyroid cancer.

Radioiodine therapy in the different stages of differentiated thyroid cancer.

Journal: Best practice & research. Clinical endocrinology & metabolism

Published: September 23, 2022

Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors.

Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors.

Journal: Cancers

Published: July 15, 2022

Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients.

Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients.

Journal: Journal of clinical medicine

Published: January 11, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026